Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

SBI Nifty Midcap 150 Index Fund · Regular ✕Axis Nifty Next 50 Index Fund · Regular ✕

Growth of ₹10,000

Basics

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
CategoryIndex Funds (Equity)Index Funds (Equity)
PlanRegularRegular
Fund houseSBIAxis
NAV₹19.4515₹17.5968
NAV date20 Nov 202620 Nov 2026
History—4.8 years
Expense ratio0.9%1.2%
StarsNot rated★★★★★
Growth Score—62.50

Returns

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
1 month—+6.52%
3 months—−1.50%
6 months—+5.44%
YTD—+5.42%
1 year—+5.07%
3 years (CAGR)—+15.80%
5 years (CAGR)——
10 years (CAGR)——
Since launch—+11.96%

Risk

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
Volatility—20.3%
Downside volatility—13.4%
Sharpe—0.46
Sortino—0.69
Calmar—0.59
Return / risk—0.78
Deepest fall—−26.59%
Days to recover——
Below its high—−6.17%

Against benchmark

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
Alpha—−0.56%
Beta—1.00
R²—100.0%
Up capture—98.5%
Down capture—100.3%
Tracking error—0.2%
Information ratio—−2.54
Treynor—0.08

Consistency

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
Best 1-year—+71.01%
Middle 1-year—+7.03%
Worst 1-year—−12.93%
1-year periods with a loss—26.4%
Middle 3-year—+17.32%
Positive months—69.4%
Best day—+4.73%
Worst day—−9.25%
Worst 5% day—−2.05%
Positive days—57.5%
NAVs a year—251

SIP of ₹10,000 a month

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
5-year XIRR——
5-year value——
3-year XIRR—+7.04%
1-year XIRR—+8.85%

Holdings overlap i

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
SBI Nifty Midcap 150 Index Fund—0%
Axis Nifty Next 50 Index Fund0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Sectors and company size

SBI Nifty Midcap 150 Index FundAxis Nifty Next 50 Index Fund
Large companies5.8%95.5%
Mid companies91.7%4.6%
Small companies2.5%—
Top 10 holdings18.3%33.9%
Largest sectorPharmaceuticals & Biotechnology 10%Power 9%

Search Growth